{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:18:58Z","timestamp":1718410738069},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.7759\/cureus.62357","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:43:26Z","timestamp":1718361806000},"source":"Crossref","is-referenced-by-count":0,"title":["Sertraline-Induced Galactorrhoea: A Case Report"],"prefix":"10.7759","author":[{"given":"Jihane","family":"Moussaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Barrimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Galactorrhea: rapid evidence review","volume":"106","author":"Bruehlman RD","year":"2022","unstructured":"Bruehlman RD, Winters S, McKittrick C. Galactorrhea: rapid evidence review. Am Fam Physician. 2022, 106:695-700.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2021.191","article-title":"Sertraline induced oromandibular dystonia and galactorrhea: a case report","volume":"33","author":"Doruk N","year":"2021","unstructured":"Doruk N, Dogrul BN. Sertraline induced oromandibular dystonia and galactorrhea: a case report. Psychiatr Danub. 2021, 33:191-2. 10.24869\/psyd.2021.191","journal-title":"Psychiatr Danub"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200302010-00003","article-title":"Hyperprolactinemia: pathophysiology and management","volume":"2","author":"Verhelst J","year":"2003","unstructured":"Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol. 2003, 2:23-32. 10.2165\/00024677-200302010-00003","journal-title":"Treat Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0193-953x(05)70009-5","article-title":"Psychoneuroendocrinology of depression","volume":"21","author":"Nicholas L","year":"1998","unstructured":"Nicholas L, Dawkins K, Golden RN. Psychoneuroendocrinology of depression. Psychiatr Clin North Am. 1998, 21:341-57. 10.1016\/s0193-953x(05)70009-5","journal-title":"Psychiatr Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5152\/npa.2015.7314","article-title":"Sertraline Induced Galactorrhea","volume":"52","author":"\u00d6zten E","year":"2015","unstructured":"\u00d6zten E, Hizli Sayar G, G\u00f6\u011f\u00e7eg\u00f6z G\u00fcl I, Ceylan ME. Sertraline Induced Galactorrhea. Noro Psikiyatr Ars. 2015, 52:202-3. 10.5152\/npa.2015.7314","journal-title":"Noro Psikiyatr Ars"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300412","article-title":"From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions","volume":"29","author":"Emiliano AB","year":"2004","unstructured":"Emiliano AB, Fudge JL. From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology. 2004, 29:833-46. 10.1038\/sj.npp.1300412","journal-title":"Neuropsychopharmacology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2009.07.006","article-title":"Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman","volume":"32","author":"Mahasuar R","year":"2010","unstructured":"Mahasuar R, Majhi P, Ravan JR. Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman. Gen Hosp Psychiatry. 2010, 32:341.e11-3. 10.1016\/j.genhosppsych.2009.07.006","journal-title":"Gen Hosp Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000203200.96205.34","article-title":"Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms","volume":"26","author":"Hedenmalm K","year":"2006","unstructured":"Hedenmalm K, G\u00fczey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol. 2006, 26:192-7. 10.1097\/01.jcp.0000203200.96205.34","journal-title":"J Clin Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch ME","year":"2005","unstructured":"Molitch ME. Medication-induced hyperprolactinemia. Mayo Clin Proc. 2005, 80:1050-7. 10.4065\/80.8.1050","journal-title":"Mayo Clin Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/258663-sertraline-induced-galactorrhoea-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:43:29Z","timestamp":1718361809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/258663-sertraline-induced-galactorrhoea-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.62357","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}